Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy

Journal of Infectious Diseases

Volumn 201, Issue 7, 2010, Pages 1035-1044

  Patel, Kunjal ^a,b   Shapiro, David E ^a,b   Brogly, Susan B ^a,b   Livingston, Elizabeth G ^d   Stek, Alice M ^e   Bardeguez, Arlene D ^f   Tuomala, Ruth E ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EMTRICITABINE; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PRENATAL CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 77749316885     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651232     Document Type: Article

References (22)

1. 1. Lorenzi P, Spicher VM, Laubereau B, et al. Antiretroviral therapies in pregnancy: maternal, fetal, and neonatal effects. AIDS 1998; 12:F241-F247. (Pubitemid 28558591)
2. The European Collaborative Study and the Swiss Mother+Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14:2913-2920.
3. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIVinfected women. J Acquir Immune Defic Syndr 2003; 32:380-387.
4. Thorne C, Patel D, Newell ML for the European Collaborative Study. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18:2337-2339.
5. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with and increased risk of preterm delivery, low birthweight, or stillbirth? J Infect Dis 2006; 193:1195-1201.
6. Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during the era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Pediatrics 2007; 119:e900-e906.
7. 7. Ravizza M, Martinelli P, Bucceri A, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis 2007; 195:913-914. (Pubitemid 46363938)
8. 8. Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007;21:1019-1026. (Pubitemid 46684333)
9. 9. Martin F, Taylor GP. Increased rates of preterm delivery are associated with the initiation of highly active antiretroviral therapy during pregnancy: a single-center cohort study. J Infect Dis 2007; 196:558-561. (Pubitemid 47206102)
10. Grosch-Woerner I, Puch K, Maier RF, et al. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/ Austrian cohort of HIV-1-infected women. HIV Med 2008;9:6-13.
11. 11. Tuomala RE, Shapiro DE, Mofenson LM, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002;346:1863-1870. (Pubitemid 34603030)
12. 12. Szyld EG, Warley EM, Freimanis L, et al. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS 2006;20:2345-2353. (Pubitemid 44789537)
13. 13. Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007;21:607-615. (Pubitemid 46303654)
14. Thorne C, Fiore S, Rudin C. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2003;348:471-472.
15. 15. Watts DH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med 2002;346:1879-1891. (Pubitemid 34603032)
16. Centers for Disease Control and Prevention (CDC). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
17. Kumar RM, Uduman SA, Khurranna AK. Impact of maternal HIV-1 infection on perinatal outcome. Int J Gynaecol Obstet 1995;49:137-143.
18. 18. Newell ML, Dunn DT, Peckham CS, Semprini AE, Pardi G. Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996;10:1675-1681. (Pubitemid 26394986)
19. 19. Stratton P, Tuomala RE, Abboud R, et al. Obstetric and newborn outcomes in a cohort and HIV-infected pregnant women: a report of the Women and Infants Transmission Study. J Acquir Immune Defic Syndr 1999;20:179-186. (Pubitemid 29063717)
20. Graves C, Porter R, Ma K, et al. Preterm labor in pregnancies complicated by HIV. Am J Obstet Gynecol 2006;195(6):S55.
21. Tuomala RE, Yawetz S. Protease inhibitor use during pregnancy: Is there an obstetrical risk? J Infect Dis 2006;193:1191-1194.
22. Perinatal HIV Guidelines Working Group. Public Health Service task force recommendations for use of antiretroviral drugs in pregnant HIVinfected women for maternal health and interventions to reduce perinatal HIV Transmission in the United States. 29 April 2009. http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL.pdf. Accessed 19 June 2009.